opac header image

Genomics in cancer drug discovery and development (Record no. 20655)

MARC details
000 -LEADER
fixed length control field 05835cam a2200757Ia 4500
001 - CONTROL NUMBER
control field ocn123420906
003 - CONTROL NUMBER IDENTIFIER
control field OCoLC
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20141103172207.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS
fixed length control field m o d
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr cnu---unuuu
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 070423s2007 ne af ob 001 0 eng d
040 ## - CATALOGING SOURCE
Original cataloging agency
Language of cataloging eng
Transcribing agency N$T
Modifying agency YDXCP
-- OCLCQ
-- QCL
-- MERUC
-- UBY
-- E7B
-- IDEBK
-- OCLCQ
-- OPELS
-- OCLCQ
-- NLGGC
-- OPELS
-- OCLCF
019 ## -
-- 163616130
-- 441774585
-- 505070588
-- 648164248
-- 695553852
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9780080471013 (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 0080471013 (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 0120066963 (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9780120066964 (electronic bk.)
029 1# - (OCLC)
OCLC library identifier NLGGC
System control number 33127289X
029 1# - (OCLC)
OCLC library identifier DEBSZ
System control number 405293194
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)123420906
Canceled/invalid control number (OCoLC)163616130
-- (OCoLC)441774585
-- (OCoLC)505070588
-- (OCoLC)648164248
-- (OCoLC)695553852
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RC270.8
Item number .G45 2007eb
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED
Subject category code subdivision 062000
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code HEA
Subject category code subdivision 039030
Source bisacsh
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 616.99/406
Edition number 22
084 ## - OTHER CLASSIFICATION NUMBER
Classification number 44.81
Number source bcl
049 ## - LOCAL HOLDINGS (OCLC)
Holding library TEFA
245 00 - TITLE STATEMENT
Title Genomics in cancer drug discovery and development
Medium [electronic resource] /
Statement of responsibility, etc. edited by Garret M. Hampton, Karol Sikora.
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Place of publication, distribution, etc. Amsterdam, NE ;
-- Boston, MA :
Name of publisher, distributor, etc. Elsevier,
Date of publication, distribution, etc. c2007.
300 ## - PHYSICAL DESCRIPTION
Extent 1 online resource (xix, 409 p., [16] p. of col. plates) :
Other physical details ill.
336 ## - CONTENT TYPE
Content type term tekst
Content type code txt
Source rdacontent/dut
337 ## - MEDIA TYPE
Media type term computer
Media type code c
Source rdamedia/dut
338 ## - CARRIER TYPE
Carrier type term online bron
Carrier type code cr
Source rdacarrier/dut
490 1# - SERIES STATEMENT
Series statement Advances in cancer research,
International Standard Serial Number 0065-230X ;
Volume/sequential designation v. 96
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc Includes bibliographical references and index.
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note Contributors to Volume 96 -- Introduction / Garret M. Hampton, Karol Sikora -- Biomarker Discovery in Epithelial Ovarian Cancer by Genomic Approaches / Samuel C. Mok, Kevin M. Elias, Kwong-Kwok Wong, Kae Ho, Tomas Bonome, and Michael J. Birrer -- Mass Spectrometry: Uncovering the Cancer Proteome for Diagnostics / Da-Elene van der Merwe, Katerina Oikonomopoulou, John Marshall, and Eleftherios P. Diamandis -- Microarrays to Identify New Therapeutic Strategies for Cancer / Christopher Sears and Scott A. Armstrong -- The Application of siRNA Technology to Cancer Biology Discovery / Uta Fuchs and Arndt Borkhardt -- Ribozyme Technology for Cancer Gene Target Identification and Validation / Qi-Xiang Li, Philip Tan, Ning Ke, and Flossie Wong-Staal -- Cancer Cell-Based Genomic and Small Molecule Screens / Jeremy S. Caldwell -- Tumor Antigens as Surrogate Markers and Targets for Therapy and Vaccines / Angus Dalgleish and Hardev Pandha -- Practices and Pitfalls of Mouse Cancer Models in Drug Discovery / Andrew L. Kung -- Pharmacodynamic Biomarkers for Molecular Cancer Therapeutics / Debashis Sarker and Paul Workman -- Biomarker Assay Translation from Discovery to Clinical Studies in Cancer Drug Development: Quantification of Emerging Protein Biomarkers / Jean W. Lee, Daniel Figeys, and Julian Vasilescu -- Molecular Optical Imaging of Therapeutic Targets of Cancer / Kostantin Sokolov, Dawn Nida, Michael Descour, Alicia Lacy, Matthew Levy, Brad Hall, Su Dharmawardhane, Andrew Ellington, Brian Korgel, and Rebecca Richards-Kortum -- Personalized Medicine for Cancer: From Molecular Signature to Therapeutic Choice / Karol Sikora -- Cancer Drug Approval in the United States, Europe, and Japan / R.A.V. Milsted -- Index.
588 ## - SOURCE OF DESCRIPTION NOTE
Source of description note Description based on print version record.
520 ## - SUMMARY, ETC.
Summary, etc. The Advances in Cancer Research series provides invaluable information on the exciting and fast-moving field of cancer research. This volume stands as the first ever thematic volume in the series, focusing on the topic of genomics in cancer drug development. The chapters included in this book represent the cutting-edge information in the field and span such topics as Mass Spectrometry: Uncovering the Cancer Proteome for Diagnostics; Biomarker Discovery in Epithelial Ovarian Cancer by Genomic Approaches; The Application of siRNA Technology to Cancer Biology Discovery; Ribozyme Technology for Cancer Gene Target Identification and Validation; Cancer Cell-Based Genomic and Small Molecule Screens; Tumour Antigens as Surrogate Markers and Targets for Therapy and Vaccines; Practices and Pitfalls of Mouse Cancer Models in Drug Discovery; Biomarker Assay Translation from Discovery to Clinical Studies in Cancer Drug Development - Quantification of Emerging Protein Biomarkers; Molecular Optical Imaging of Therapeutic Targets of Cancer; Cancer Drug Approval in the United States, Europe and Japan.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Cancer
General subdivision Treatment.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Cancer
General subdivision Research.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Cancer
General subdivision Genetic aspects.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Tumors
General subdivision Genetic aspects.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Genomics.
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Genomics
General subdivision methods.
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Neoplasms
General subdivision therapy.
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element MEDICAL
General subdivision Oncology.
Source of heading or term bisacsh
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element HEALTH & FITNESS
General subdivision Diseases
-- Cancer.
Source of heading or term bisacsh
650 #4 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Electronic books.
650 17 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Kanker.
Source of heading or term gtt
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Cancer
General subdivision Genetic aspects.
Source of heading or term fast
Authority record control number (OCoLC)fst00845368
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Cancer
General subdivision Research.
Source of heading or term fast
Authority record control number (OCoLC)fst00845497
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Cancer
General subdivision Treatment.
Source of heading or term fast
Authority record control number (OCoLC)fst00845538
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Genomics.
Source of heading or term fast
Authority record control number (OCoLC)fst00940228
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Tumors
General subdivision Genetic aspects.
Source of heading or term fast
Authority record control number (OCoLC)fst01158768
655 #4 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Electronic books.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Hampton, Garret M.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Sikora, Karol.
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Relationship information Print version:
Title Genomics in cancer drug discovery and development.
Place, publisher, and date of publication Amsterdam, NE ; Boston, MA : Elsevier, c2007
International Standard Book Number 0120066963
-- 9780120066964
Record control number (OCoLC)80548348
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE
Uniform title Advances in cancer research ;
Volume number/sequential designation v. 96.
International Standard Serial Number 0065-230X
856 40 - ELECTRONIC LOCATION AND ACCESS
Materials specified ScienceDirect
Uniform Resource Identifier <a href="http://www.sciencedirect.com/science/book/9780120066964">http://www.sciencedirect.com/science/book/9780120066964</a>
938 ## -
-- YBP Library Services
-- YANK
-- 2551340
938 ## -
-- ebrary
-- EBRY
-- ebr10167106
938 ## -
-- Ingram Digital eBook Collection
-- IDEB
-- 96284
938 ## -
-- EBSCOhost
-- EBSC
-- 187387
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Koha item type E(electronic)-Books
994 ## -
-- C0
-- TEF

No items available.